Logo image of IUR.DE

KAP AG (IUR.DE) Stock Fundamental Analysis

FRA:IUR - Deutsche Boerse Ag - DE0006208408 - Common Stock - Currency: EUR

10.9  0 (0%)

Fundamental Rating

2

Overall IUR gets a fundamental rating of 2 out of 10. We evaluated IUR against 15 industry peers in the Industrial Conglomerates industry. IUR has a bad profitability rating. Also its financial health evaluation is rather negative. IUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

IUR had negative earnings in the past year.
IUR had a positive operating cash flow in the past year.
IUR had negative earnings in 4 of the past 5 years.
In the past 5 years IUR always reported a positive cash flow from operatings.
IUR.DE Yearly Net Income VS EBIT VS OCF VS FCFIUR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

IUR has a worse Return On Assets (-17.76%) than 93.33% of its industry peers.
IUR has a worse Return On Equity (-38.65%) than 93.33% of its industry peers.
Industry RankSector Rank
ROA -17.76%
ROE -38.65%
ROIC N/A
ROA(3y)-6.1%
ROA(5y)-1.54%
ROE(3y)-13.28%
ROE(5y)-4.05%
ROIC(3y)N/A
ROIC(5y)N/A
IUR.DE Yearly ROA, ROE, ROICIUR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

The Gross Margin of IUR (59.04%) is better than 73.33% of its industry peers.
In the last couple of years the Gross Margin of IUR has grown nicely.
The Profit Margin and Operating Margin are not available for IUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.1%
GM growth 5Y2.29%
IUR.DE Yearly Profit, Operating, Gross MarginsIUR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

IUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IUR has about the same amount of shares outstanding.
IUR has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, IUR has a worse debt to assets ratio.
IUR.DE Yearly Shares OutstandingIUR.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
IUR.DE Yearly Total Debt VS Total AssetsIUR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

IUR has an Altman-Z score of 1.37. This is a bad value and indicates that IUR is not financially healthy and even has some risk of bankruptcy.
IUR has a worse Altman-Z score (1.37) than 80.00% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that IUR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.44, IUR is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACCN/A
WACC7.34%
IUR.DE Yearly LT Debt VS Equity VS FCFIUR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.38 indicates that IUR should not have too much problems paying its short term obligations.
The Current ratio of IUR (1.38) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.81 indicates that IUR may have some problems paying its short term obligations.
IUR has a Quick ratio of 0.81. This is amonst the worse of the industry: IUR underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
IUR.DE Yearly Current Assets VS Current LiabilitesIUR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

The earnings per share for IUR have decreased strongly by -14575.00% in the last year.
IUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.59%.
Measured over the past years, IUR shows a decrease in Revenue. The Revenue has been decreasing by -6.64% on average per year.
EPS 1Y (TTM)-14575%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13000%
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y-9.94%
Revenue growth 5Y-6.64%
Sales Q2Q%-70.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IUR.DE Yearly Revenue VS EstimatesIUR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IUR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IUR.DE Price Earnings VS Forward Price EarningsIUR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

IUR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IUR is cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.61
IUR.DE Per share dataIUR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.87%, IUR is a good candidate for dividend investing.
IUR's Dividend Yield is rather good when compared to the industry average which is at 3.80. IUR pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, IUR pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IUR.DE Yearly Dividends per shareIUR.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IUR.DE Yearly Income VS Free CF VS DividendIUR.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

KAP AG

FRA:IUR (6/10/2025, 7:00:00 PM)

10.9

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)03-12 2025-03-12
Earnings (Next)08-29 2025-08-29
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners25.7%
Ins Owner ChangeN/A
Market Cap84.69M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.87%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF 5.06
P/B 0.72
P/tB 0.83
EV/EBITDA 2.61
EPS(TTM)-5.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)2.16
OCFY19.78%
SpS32.5
BVpS15.2
TBVpS13.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.76%
ROE -38.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.04%
FCFM N/A
ROA(3y)-6.1%
ROA(5y)-1.54%
ROE(3y)-13.28%
ROE(5y)-4.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.1%
GM growth 5Y2.29%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA 1.08
Cap/Depr 42.95%
Cap/Sales 10.48%
Interest Coverage N/A
Cash Conversion 34.76%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.37
F-Score4
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)65.33%
Cap/Depr(5y)78.67%
Cap/Sales(3y)10.8%
Cap/Sales(5y)9.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14575%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13000%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y-9.94%
Revenue growth 5Y-6.64%
Sales Q2Q%-70.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.53%
OCF growth 3Y26.34%
OCF growth 5Y-13.95%